Safe administration of vancomycin through a novel midline catheter: A randomized, prospective clinical trial

Journal of Vascular Access

Volumn 15, Issue 4, 2014, Pages 251-256

  Caparas, Jona V ^a   Hu, Jian Ping ^a  

^a NEW YORK HOSPITAL QUEENS   (United States)

Author keywords

Infusion phlebitis; INS standards; Midline; PH; Phlebitis; Vancomycin

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT;

AGED; ARTICLE; CATHETER; CATHETER INFECTION; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; INFUSION PUMP; MAJOR CLINICAL STUDY; MALE; MIDLINE CATHETER; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PHLEBITIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; ADVERSE EFFECTS; CATHETER OBSTRUCTION; CATHETERIZATION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DEVICES; DRUG ADMINISTRATION; ECONOMICS; EQUIPMENT DESIGN; HEALTH CARE COST; INDWELLING CATHETER; INTRAVENOUS DRUG ADMINISTRATION; NEW YORK; PH; PROSTHESIS-RELATED INFECTIONS; TIME FACTOR; TREATMENT OUTCOME; UPPER EXTREMITY DEEP VEIN THROMBOSIS; UPPER LIMB; VASCULARIZATION;

AGED; ANTI-BACTERIAL AGENTS; CATHETER OBSTRUCTION; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; COST SAVINGS; COST-BENEFIT ANALYSIS; DRUG ADMINISTRATION SCHEDULE; EQUIPMENT DESIGN; FEMALE; HEALTH CARE COSTS; HUMANS; HYDROGEN-ION CONCENTRATION; INFUSIONS, INTRAVENOUS; MALE; NEW YORK CITY; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; TIME FACTORS; TREATMENT OUTCOME; UPPER EXTREMITY; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VANCOMYCIN;

EID: 84905283199     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/jva.5000220     Document Type: Article

References (43)

1. O'Grady NP, Alexander M, Burns LS, et al. CDC guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(4):S3, S5.
2. Stoker R. Accelerated Seldinger technique. Managing Inf Cont. 2009;March:32-35.
3. Dawson RB, Moreau NL. Midlines-an essential tool in CLABSI reduction. Infect Control Today. 2013;17(3):42-45.
4. Warrington WG, Penoyer DA, Kamps T, et al. Outcomes of using a modified Seldinger technique for long term intravenous therapy in hospitalized patients with difficult venous access. JAVA. 2012;17(1):24-31.
5. Caparas J. Staff Education/Training Aids Implementation of Advanced Midline Catheter. Scientific Poster, presented at: INS Annual Convention & Industrial Exhibition; May 2013.
6. Gorski LA, Eddins J, Hadaway L, et al. Infusion nursing standards of practice (revised 2011). JIN. 2013;34(1S): S37-S38.
7. rd ed. St. Louis, MO: Saunders/ Elsevier; 2010:204-228.
8. rd ed. St. Louis, MO: Saunders/Elsevier; 2010:480-494.
9. Cheung E, Baerlocher MO, Asch M, Myers A. Venous access: a practical review for 2009. Can Fam Physician. 2009;55(5):494-496.
10. rd ed. St. Louis, MO: Saunders/Elsevier; 2010:391-436.
11. rd ed. St. Louis, MO: Saunders/Elsevier; 2010:456-479.
12. Mirtallo J, Canada T, Johnson D, et al; American Society for Parenteral and Enteral Nutrition. Safe practices for parenteral nutrition: practice guidelines for safe practice for parenteral nutrition. J Parenter Enteral Nutr. 2004; 28(6):S39-S70.
13. Isaacs JW, Millikan WJ, Stackhouse J, Hersh T, Rudman D. Parenteral nutrition of adults with a 900 milliosmolar solution via peripheral veins. Am J Clin Nutr. 1977;30(4): 552-559.
14. Pettit J, Wyckoff M. Peripherally Inserted Central Catheters: Guidelines for Practice. 2nd ed. Glenview, IL: National Association of Neonatal Nurses: 2007.
15. Gura KM. Is there still a role for peripheral parenteral nutrition? Nutr Clin Pract. 2009; 24(6):709-717.
16. Krzywda EA, Meyer D. Parenteral nutrition. In: Alexander M, Corrigan A, Gorski L, et al. Infusion Nursing: An Evidence-Based Approach. 3rd ed. St. Louis, MO: Saunders/ Elsevier; 2010:316-350.
17. th ed. Boston, MA: Jones & Bartlett; 2005:352-412.
18. nd ed. Pittsburgh, PA: ONS; 2005.
19. Bishop L, Dougherty L, Bodenham A, et. al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol. 2007;29(4): 261-278.
20. Fonkalsrud EW, Murphy J, Smith FG Jr. Effect of pH in glucose infusions on development of thrombophlebitis. J Surg Res. 1968;8(11):539-543.
21. Lewis GBH, Hecker JF. Infusion thrombophlebitis. Br J Anaesth. 1985;57(2):220-233.
22. Tagalakis V, Kahn SR, Libman M, Blostein M. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med. 2002;113(2):146-151.
23. Campbell L. I.v.-related phlebitis, complications and length of hospital stay: 1. Br J Nurs. 1998;7(21):1304-1306, 1308-1312.
24. Harrigan CA. A cost-effective guide for the prevention of chemical phlebitis caused by the pH of the pharmaceutical agent. NITA. 1984;7(6):478-482.
25. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med. 1991;114(10): 845-854.
26. Monreal M, Quilez F, Rey-Joly C, et al. Infusion phlebitis in patients with acute pneumonia: a prospective study. Chest. 1999;115(6):1576-1580.
27. Cicolini G, Bonghi AP, Di Labio L, Di Mascio R. Position of peripheral venous cannulae and the incidence of thrombophlebitis: an observational study. J Adv Nurs. 2009; 65(6):1268-1273.
28. Tripathi S, Kaushik V, Singh V. Peripheral IVs: factors affecting complications and patency-a randomized controlled trial. J Infus Nurs. 2008;31(3):182-188.
29. Hawes ML. A proactive approach to combating venous depletion in the hospital setting. JIN. 2007;30(1):33-44.
30. Kirschner R. Contrast media-phlebitis implications. US Radiology. 2010;2(1):27-30.
31. Kokotis K. Preventing chemical phlebitis. Nursing. 1998; 28(11):41-46.
32. Roszell S, Jones C. Intravenous administration issues. JIN. 2010;33(2):112-118.
33. Jones ER. Relationship between pH of intravenous medications and phlebitis: an experimental study. NITA. 1982; 5(4):273-276.
34. Lanbeck P, Odenholt I, Paulsen O. Antibiotics differ in their tendency to cause infusion phlebitis: a prospectiveobservational study. Scand J Infect Dis. 2002;34(7): 512-519.
35. Mowry JL, Hartman LS. Intravascular thrombophlebitis related to the peripheral infusion of amiodarone and vancomycin. West J Nurs Res. 2011;33(3):457-471.
36. Balliad P, Peterson S. Midline Catheter Reduces Infiltrations for Coronary Artery Bypass Graft Patients. Scientific Poster, presented at: INS Annual Convention & Industrial Exhibition; May 2013.
37. LaRue GD, Peterson M. The impact of dilution on intravenous therapy. JIN. 2011;34(2):117-123.
38. Bohm NM, Wong JG. Bullous dermatosis associated with vancomycin extravasation. Am J Med Sci. 2012;343(2): 117-119.
39. Hoelen DWM, Tjan DHT, van Vugt R, van der Meer YG, van Zanten AR. Severe local vancomycin induced skin necrosis. Br J Clin Pharmacol. 2007;64(4): 553-554.
40. Periard D, Monney P, Waeber G, et al. Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy. J Thromb Haemost. 2008;6(8):1281-1288.
41. Bonizzoli M, Batacchi S, Cianchi G, et al. Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Med. 2011;37(2):284-289.
42. Prandoni P. Prophylaxis of catheter-related thrombosis in cancer patients. Lancet. 2009;373(9663):523-524.
43. Chopra V, Flanders SA, Saint S. The problem with peripherally inserted central catheters. JAMA. 2012;308(15): 1527-1528.